{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:41:39Z","timestamp":1761986499629,"version":"3.44.0"},"reference-count":32,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2017,3]]},"abstract":"<jats:p>Penicillin<jats:sup>i<\/jats:sup> allergy is a potentially serious adverse reaction that impacts on antibacterial treatment options. Although it is commonly reported and recorded in medical records, only a minority of patients with a label of penicillin allergy actually have the condition confirmed. The term \u2018allergy\u2019 may be incorrectly applied to adverse reactions that do not have an immunological basis and inappropriate labelling of penicillin allergy can lead to the unnecessary avoidance of penicillins and other beta-lactam antibacterials. Here, we discuss key features that help to distinguish patients at low or high risk of having a true penicillin allergy, summarise what is known about the risk of allergic reactions to other beta-lactam antibacterials in patients with penicillin allergy and discuss the steps to consider when assessing a label of penicillin allergy.<\/jats:p>","DOI":"10.1136\/dtb.2017.3.0463","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T07:05:47Z","timestamp":1489043147000},"page":"33-36","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Penicillin allergy\u2014getting the label right"],"prefix":"10.1136","volume":"55","member":"239","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"key":"2025082623380956000_55.3.33.1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/cea.12468","article-title":"Management of allergy to penicillins and other beta-lactams","volume":"45","author":"Mirakian","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"2025082623380956000_55.3.33.2","unstructured":"Clinical Guideline Centre, 2014. Drug allergy: diagnosis and management of drug allergy in adults, children and young people [online]. Available: https:\/\/www.nice.org.uk\/guidance\/cg183\/evidence\/drug-allergy-full-guideline-193159693 [Accessed 15 February 2017]."},{"key":"2025082623380956000_55.3.33.3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1742-1241.1994.tb09729.x","article-title":"Penicillin allergy: a study of incidence as reported by patients","volume":"48","author":"Kerr","year":"1994","journal-title":"Br J Clin Pract"},{"key":"2025082623380956000_55.3.33.4","first-page":"212","article-title":"Hypersensitivity to beta-lactam antibiotics: a three-year study","volume":"48","author":"Mota","year":"2016","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"2025082623380956000_55.3.33.5","unstructured":"Public Health England, 2016. Management of infection guidance for primary care for consultation and local adaptation [online]. Available: https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/524984\/Management_of_infection_guidance_for_primary_care_for_consultation_and_local_adaptation.pdf [Accessed 15 February 2017]."},{"key":"2025082623380956000_55.3.33.6","unstructured":"All Wales Medicines Strategy Group, 2015. Primary care antimicrobial guidelines [online]. Available: http:\/\/www.awmsg.org\/docs\/awmsg\/medman\/Primary%20Care%20Antimicrobial%20Guidelines.pdf [Accessed 15 February 2017]."},{"key":"2025082623380956000_55.3.33.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.11.032"},{"key":"2025082623380956000_55.3.33.8","doi-asserted-by":"publisher","DOI":"10.1001\/archfami.9.8.722"},{"key":"2025082623380956000_55.3.33.9","doi-asserted-by":"publisher","DOI":"10.1016\/S1081-1206(10)62782-2"},{"key":"2025082623380956000_55.3.33.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_230.x"},{"key":"2025082623380956000_55.3.33.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.09.021"},{"key":"2025082623380956000_55.3.33.12","doi-asserted-by":"publisher","DOI":"10.1592\/phco.31.8.742"},{"key":"2025082623380956000_55.3.33.13","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000006"},{"key":"2025082623380956000_55.3.33.14","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2014-202438"},{"key":"2025082623380956000_55.3.33.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2010.04.006"},{"key":"2025082623380956000_55.3.33.16","doi-asserted-by":"publisher","DOI":"10.1111\/all.12350"},{"key":"2025082623380956000_55.3.33.17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1081-1206(10)60621-7","article-title":"Female sex as a risk factor for penicillin allergy","volume":"99","author":"Park","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2025082623380956000_55.3.33.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2009.01.034."},{"key":"2025082623380956000_55.3.33.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.03.037"},{"key":"2025082623380956000_55.3.33.20","unstructured":"Joint Formulary Committee. British National Formulary. Ed. 72. London: BMJ Group and Pharmaceutical Press, September 2016."},{"key":"2025082623380956000_55.3.33.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.08.025"},{"key":"2025082623380956000_55.3.33.22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/pai.12155","article-title":"Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children","volume":"25","author":"Zambonino","year":"2014","journal-title":"Pediatr Allergy Immunol"},{"key":"2025082623380956000_55.3.33.23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/cea.12134","article-title":"A UK national survey of investigations for beta-lactam hypersensitivity\u2014heterogeneity in practice and a need for national guidelines\u2014on behalf of British Society for Allergy and Clinical Immunology (BSACI)","volume":"43","author":"Richter","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"2025082623380956000_55.3.33.24","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2003.00280.x"},{"key":"2025082623380956000_55.3.33.25","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/all.13032","article-title":"Performance in real life of the European Network on Drug Allergy algorithm in immediate reactions to beta-lactam antibiotics","volume":"71","author":"Moreno","year":"2016","journal-title":"Allergy"},{"key":"2025082623380956000_55.3.33.26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1398-9995.2008.01713.x","article-title":"Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins","volume":"64","author":"Fern\u00e1ndez","year":"2009","journal-title":"Allergy"},{"key":"2025082623380956000_55.3.33.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2008.01903.x"},{"key":"2025082623380956000_55.3.33.28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11882-016-0594-9","article-title":"Cross-reactivity among beta-lactams","volume":"16","author":"Romano","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"2025082623380956000_55.3.33.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.otohns.2006.10.007"},{"key":"2025082623380956000_55.3.33.30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39372.829676.47"},{"key":"2025082623380956000_55.3.33.31","unstructured":"Jethwa S , 2015. Penicillin allergy: identification and management [online]. Available: http:\/\/www.pharmaceutical-journal.com\/learning\/learning-article\/penicillin-allergy-identification-and-management\/20069170.article [Accessed 21 February 2017]."},{"key":"2025082623380956000_55.3.33.32","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/cea.12788","article-title":"BSACI guideline: prescribing an adrenaline auto-injector","volume":"46","author":"Ewan","year":"2016","journal-title":"Clin Exper Allergy"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2017.3.0463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T06:38:20Z","timestamp":1756276700000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2017.3.0463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3,9]]},"published-print":{"date-parts":[[2017,3]]}},"alternative-id":["10.1136\/dtb.2017.3.0463"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2017.3.0463","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2017,3]]}}}